Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosis.

Ameneh ShokatiAbdorreza Naser MoghadasiAndisheh GhashghaeiMohammad Ali SahraianBahram ChahardouliSeyed Asadollah MousaviJafar Ai Mohsen Nikbakht

Published in: Molecular biology reports (2024)

We hope that our protocol for clinical manufacturing of PLMSCs according to GMP standards will assist researchers in isolating MSCs from placental tissue for clinical and pre-clinical applications.

Keyphrases

multiple sclerosis
healthcare
randomized controlled trial
primary care
mesenchymal stem cells
escherichia coli
cystic fibrosis
bone marrow
biofilm formation
pseudomonas aeruginosa
induced pluripotent stem cells